Cameco (NYSE:CCJ) Stock Price Up 1.8% – Here’s What Happened

Cameco Corporation (NYSE:CCJ) (TSE:CCO)’s stock price traded up 1.8% during mid-day trading on Friday . The stock traded as high as $123.32 and last traded at $121.16. 4,724,098 shares traded hands during mid-day trading, a decline of 0% from the average session volume of 4,746,609 shares. The stock had previously closed at $119.03.

Trending Headlines about Cameco

Here are the key news stories impacting Cameco this week:

• Positive Sentiment: GLJ Research reiterated a buy rating on Cameco, supporting upside sentiment from some sell‑side firms that expect continued strength in uranium demand. GLJ Research Reiterates Buy for Cameco (NYSE:CCJ)
• Positive Sentiment: MarketBeat highlighted a bullish, longer-term case that global adoption of nuclear power could keep demand for uranium—and Cameco’s revenues—elevated, a thematic driver that has helped CCJ’s recent run. Can Cameco Continue Its Run?
• Neutral Sentiment: Scotiabank trimmed its FY2027 EPS forecast for Cameco slightly (from $1.53 to $1.48) but left an Outperform rating in place—this is a modest earnings haircut rather than a full-scale outlook change, so the impact may be limited unless revisions accelerate. MarketBeat: Cameco / Scotiabank Note
• Negative Sentiment: Zacks Research downgraded Cameco from “strong-buy” to “hold,” which can pressure momentum players and reduce near-term buying conviction. Zacks.com
• Negative Sentiment: There was unusually large put option activity—roughly 28,210 puts (about a 942% increase vs. average)—indicating elevated hedging or speculative bearish positioning that can amplify intraday volatility and signal downside risk if sentiment shifts. Investors Buy High Volume of Cameco Put Options

Wall Street Analyst Weigh In

Several research firms have weighed in on CCJ. The Goldman Sachs Group reissued a “buy” rating and issued a $131.00 target price on shares of Cameco in a research note on Wednesday, February 4th. Wall Street Zen cut Cameco from a “buy” rating to a “hold” rating in a research note on Saturday, November 8th. National Bank Financial reissued an “outperform” rating on shares of Cameco in a research note on Thursday, November 6th. UBS Group assumed coverage on shares of Cameco in a research note on Monday, November 10th. They issued a “neutral” rating and a $140.00 target price for the company. Finally, Royal Bank Of Canada increased their target price on shares of Cameco from $150.00 to $160.00 and gave the stock an “outperform” rating in a report on Tuesday. One investment analyst has rated the stock with a Strong Buy rating, twelve have assigned a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $143.03.

Cameco Trading Up 1.8%

The company has a current ratio of 2.47, a quick ratio of 1.85 and a debt-to-equity ratio of 0.14. The firm has a market capitalization of $52.77 billion, a P/E ratio of 124.91 and a beta of 0.99. The business has a 50 day moving average of $108.78 and a 200-day moving average of $93.40.

Cameco (NYSE:CCJ) (TSE:CCO) last released its quarterly earnings results on Friday, February 13th. The basic materials company reported $0.36 earnings per share for the quarter, beating the consensus estimate of $0.29 by $0.07. Cameco had a net margin of 17.00% and a return on equity of 9.35%. The company had revenue of $874.57 million during the quarter, compared to analysts’ expectations of $782.13 million. During the same quarter in the prior year, the company earned $0.36 earnings per share. The business’s quarterly revenue was up 1.5% compared to the same quarter last year. Analysts anticipate that Cameco Corporation will post 1.27 EPS for the current fiscal year.

Hedge Funds Weigh In On Cameco

A number of large investors have recently added to or reduced their stakes in the company. Financial Consulate Inc. acquired a new stake in Cameco in the 3rd quarter valued at approximately $25,000. Nisa Investment Advisors LLC bought a new position in shares of Cameco during the 4th quarter worth approximately $25,000. Founders Capital Management bought a new position in shares of Cameco during the 4th quarter worth approximately $27,000. Strategic Advocates LLC acquired a new stake in shares of Cameco in the third quarter valued at approximately $28,000. Finally, Mcguire Capital Advisors Inc. bought a new stake in shares of Cameco in the fourth quarter worth $28,000. Institutional investors own 70.21% of the company’s stock.

About Cameco

Cameco Corporation (NYSE: CCJ) is a leading producer of uranium and a supplier to the global nuclear power industry. Headquartered in Saskatoon, Saskatchewan, Canada, the company is engaged in the exploration, mining, milling and sale of uranium concentrate, commonly known as yellowcake, which is used as fuel for nuclear reactors. Cameco also participates in services and activities that support the front end of the nuclear fuel cycle, including processing and marketing of uranium to utilities under long‑term and spot contracts.

The company’s operations have historically centered in Canada and the United States, where it operates and develops uranium mining and processing properties.